{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:39:19Z","timestamp":1792532359502,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>The neurologic manifestations of selected tick-transmitted infections in North America and Eurasia were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>\n                      Both Powassan virus in North America, and Tick-Borne Encephalitis (TBE) virus in Eurasia can cause encephalitis, often with significant neurologic morbidity. Lyme disease,\n                      <jats:italic>Ehrlichia chaffeensis<\/jats:italic>\n                      (the cause of human monocytic ehrlichiosis [HME]), and\n                      <jats:italic>Borrelia miyamotoi<\/jats:italic>\n                      infections can cause meningitis (the third primarily in immunocompromised individuals). Patients with Lyme disease may also develop cranial neuropathy, and\/or radiculoneuropathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>\n                      Tick-borne infections are being increasingly recognized in North America and Eurasia. While many tick-borne infections can cause headaches, lethargy or other non-specific symptoms, these are generally not evidence of nervous system infection \u2013 i.e., neuroinvasive disease. The latter is less common but may occur in infections due to Powassan and TBE viruses, in HME and in Lyme disease\n                      <jats:italic>.<\/jats:italic>\n                      Patients with symptomatic nervous system infection due to Powassan or TBE virus are at high risk of developing significant neurologic impairment and sequelae.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11910-026-01530-1","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:20:58Z","timestamp":1792484458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lyme Disease and Other Tick-Borne Infections"],"prefix":"10.1007","volume":"26","author":[{"given":"John J.","family":"Halperin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Wormser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"1530_CR1","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3201\/eid2909.221912","volume":"29","author":"DW McCormick","year":"2023","unstructured":"McCormick DW, Brown CM, Bjork J, et al. Characteristics of hard tick relapsing fever caused by Borrelia miyamotoi, United States, 2013\u20132019. Emerg Infect Dis. 2023;29:1719\u201329.","journal-title":"Emerg Infect Dis"},{"key":"1530_CR2","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1099\/ijsem.0.001445","volume":"66","author":"BS Pritt","year":"2016","unstructured":"Pritt BS, Respicio-Kingry LB, Sloan LM, et al. Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper Midwestern United States. Int J Syst Evol Microbiol. 2016;66:4878\u201380.","journal-title":"Int J Syst Evol Microbiol"},{"key":"1530_CR3","unstructured":"CDC. Bartonella infection [online]. Available at: https:\/\/www.cdc.gov\/bartonella\/about\/index.html. Accessed August 12."},{"key":"1530_CR4","doi-asserted-by":"publisher","first-page":"ofaf430","DOI":"10.1093\/ofid\/ofaf430","volume":"12","author":"AA Shishido","year":"2025","unstructured":"Shishido AA, Wormser GP. A review of alpha-gal syndrome for the infectious diseases practitioner. Open Forum Infect Dis. 2025;12:ofaf430.","journal-title":"Open Forum Infect Dis"},{"key":"1530_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3201\/eid2702.202731","volume":"27","author":"KJ Kugeler","year":"2021","unstructured":"Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF. Estimating the frequency of Lyme disease diagnoses, United States, 2010\u20132018. Emerg Infect Dis. 2021;27:616\u20139.","journal-title":"Emerg Infect Dis"},{"key":"1530_CR6","unstructured":"CDC. Historic Data (2004\u20132025) Powassan Virus CDC.pdf [online]."},{"key":"1530_CR7","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7531a1","author":"S Sweeney","year":"2024","unstructured":"Sweeney S, Bullock A, Reiskind M, et al. Southward expansion of Ixodes scapularis (blacklegged) tick pathogens \u2014 Western North Carolina, November 2024\u2013August 2025. MMWR Morb Mortal Wkly Rep. 2024. https:\/\/doi.org\/10.15585\/mmwr.mm7531a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1530_CR8","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1093\/infdis\/jiae230","volume":"230","author":"P Mead","year":"2024","unstructured":"Mead P, Hinckley A, Kugeler K. Lyme disease surveillance and epidemiology in the United States: a historical perspective. J Infect Dis. 2024;230:S11\u20137.","journal-title":"J Infect Dis"},{"key":"1530_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","volume":"11","author":"U Koedel","year":"2015","unstructured":"Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol. 2015;11:446\u201356.","journal-title":"Nat Rev Neurol"},{"key":"1530_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJM199511163332004","volume":"333","author":"J Berglund","year":"1995","unstructured":"Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319\u201327.","journal-title":"N Engl J Med"},{"key":"1530_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","volume":"66","author":"AM Schwartz","year":"2017","unstructured":"Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme disease - United States, 2008\u20132015. MMWR Surveill Summ. 2017;66:1\u201312.","journal-title":"MMWR Surveill Summ"},{"issue":"8\u201316","key":"1530_CR12","first-page":"e11","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(8\u201316):e11-14.","journal-title":"Eur J Neurol"},{"key":"1530_CR13","unstructured":"CDC. Lyme Disease (Borrelia burgdorferi): 2022 Case Definition [online]. Available at: https:\/\/ndc.services.cdc.gov\/case-definitions\/lyme-disease-2022\/. Accessed 8\/16\/26."},{"key":"1530_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","volume":"72","author":"PM Lantos","year":"2021","unstructured":"Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021;72:1\u20138.","journal-title":"Clin Infect Dis"},{"key":"1530_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.7326\/0003-4819-86-6-685","volume":"86","author":"AC Steere","year":"1977","unstructured":"Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med. 1977;86:685\u201398.","journal-title":"Ann Intern Med"},{"key":"1530_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00005792-197907000-00001","volume":"58","author":"L Reik","year":"1979","unstructured":"Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine (Baltimore). 1979;58:281\u201394.","journal-title":"Medicine (Baltimore)"},{"key":"1530_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jcm.34.1.1-9.1996","volume":"34","author":"ME Aguero-Rosenfeld","year":"1996","unstructured":"Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34:1\u20139.","journal-title":"J Clin Microbiol"},{"key":"1530_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1086\/589242","volume":"47","author":"AC Steere","year":"2008","unstructured":"Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for Lyme disease. Clin Infect Dis. 2008;47:188\u201395.","journal-title":"Clin Infect Dis"},{"key":"1530_CR19","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.40.9.1340","volume":"40","author":"JJ Halperin","year":"1990","unstructured":"Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology. 1990;40:1340\u20133.","journal-title":"Neurology"},{"key":"1530_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/infdis\/161.6.1203","volume":"161","author":"AC Steere","year":"1990","unstructured":"Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis. 1990;161:1203\u20139.","journal-title":"J Infect Dis"},{"key":"1530_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1212\/WNL.41.10.1571","volume":"41","author":"JJ Halperin","year":"1991","unstructured":"Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991;41:1571\u201382.","journal-title":"Neurology"},{"key":"1530_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1212\/WNL.43.1_Part_1.169","volume":"43","author":"S Hammers Berggren","year":"1993","unstructured":"Hammers Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology. 1993;43:169\u201375.","journal-title":"Neurology"},{"key":"1530_CR23","doi-asserted-by":"crossref","unstructured":"Halperin JJ, Granger D. Intrathecal antibody synthesis \u2013 Reiber method revisited. BMC Neurol 2026.","DOI":"10.1186\/s12883-026-05004-2"},{"key":"1530_CR24","first-page":"765","volume":"71","author":"C Garin","year":"1922","unstructured":"Garin C, Bujadoux A. Paralysie par les tiques. J Med Lyon. 1922;71:765\u20137.","journal-title":"J Med Lyon"},{"key":"1530_CR25","doi-asserted-by":"publisher","first-page":"ofw085","DOI":"10.1093\/ofid\/ofw085","volume":"3","author":"GP Wormser","year":"2016","unstructured":"Wormser GP, Wormser V. Did Garin and Bujadoux actually report a case of lyme radiculoneuritis? Open Forum Infect Dis. 2016;3:ofw085.","journal-title":"Open Forum Infect Dis"},{"key":"1530_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/brain\/115.2.399","volume":"115","author":"K Hansen","year":"1992","unstructured":"Hansen K, Lebech A-M. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985\u20131990: a prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain. 1992;115:399\u2013423.","journal-title":"Brain"},{"key":"1530_CR27","doi-asserted-by":"publisher","first-page":"101411","DOI":"10.1016\/j.ttbdis.2020.101411","volume":"11","author":"CL Nordberg","year":"2020","unstructured":"Nordberg CL, Bodilsen J, Knudtzen FC, et al. Lyme neuroborreliosis in adults: a nationwide prospective cohort study. Ticks Tick Borne Dis. 2020;11:101411.","journal-title":"Ticks Tick Borne Dis"},{"key":"1530_CR28","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00431-022-04749-5","volume":"182","author":"A van Samkar","year":"2023","unstructured":"van Samkar A, Bruinsma RA, Vermeeren YM, et al. Clinical characteristics of Lyme neuroborreliosis in Dutch children and adults. Eur J Pediatr. 2023;182:1183\u20139.","journal-title":"Eur J Pediatr"},{"key":"1530_CR29","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/brain\/awac206","volume":"145","author":"JJ Halperin","year":"2022","unstructured":"Halperin JJ, Eikeland R, Branda JA, Dersch R. Lyme neuroborreliosis: known knowns, known unknowns. Brain. 2022;145:2635\u201347.","journal-title":"Brain"},{"key":"1530_CR30","doi-asserted-by":"publisher","first-page":"790762","DOI":"10.1155\/2015\/790762","volume":"2015","author":"D Tveitnes","year":"2015","unstructured":"Tveitnes D, Oymar K. Gender differences in childhood lyme neuroborreliosis. Behav Neurol. 2015;2015:790762.","journal-title":"Behav Neurol"},{"key":"1530_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MOP.0000000000001326","volume":"36","author":"E Taylor-Salmon","year":"2024","unstructured":"Taylor-Salmon E, Shapiro ED. Tick-borne infections in children in North America. Curr Opin Pediatr. 2024;36:156\u201363.","journal-title":"Curr Opin Pediatr"},{"key":"1530_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.idc.2022.03.002","volume":"36","author":"CA McCarthy","year":"2022","unstructured":"McCarthy CA, Helis JA, Daikh BE. Lyme disease in children. Infect Dis Clin North Am. 2022;36:593\u2013603.","journal-title":"Infect Dis Clin North Am"},{"key":"1530_CR33","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1212\/WNL.43.12.2609","volume":"43","author":"AL Belman","year":"1993","unstructured":"Belman AL, Iyer M, Coyle PK, Dattwyler R. Neurologic manifestations in children with North American Lyme disease. Neurology. 1993;43:2609\u201314.","journal-title":"Neurology"},{"key":"1530_CR34","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1093\/pch\/pxaa068.016","volume":"25","author":"S Zahradnik","year":"2020","unstructured":"Zahradnik S, Barrowman N, Tsampalieros A, Harrison M-A, Bowes J, Brophy J. Lyme disease in eastern Ontario: a paediatric centre\u2019s experience from 2009\u20132018. Paediatr Child Health. 2020;25:e6\u20137.","journal-title":"Paediatr Child Health"},{"key":"1530_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.14745\/ccdr.v43i10a01","volume":"43","author":"S Gasmi","year":"2017","unstructured":"Gasmi S, Ogden NH, Lindsay LR, et al. Surveillance for Lyme disease in Canada: 2009\u20132015. Can Commun Dis Rep. 2017;43:194\u20139.","journal-title":"Can Commun Dis Rep"},{"key":"1530_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/jnnp.38.5.452","volume":"38","author":"HC Hopf","year":"1975","unstructured":"Hopf HC. Peripheral neuropathy in acrodermatitis chronica atrophicans (Herxheimer). J Neurol Neurosurg Psychiatry. 1975;38:452\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1530_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1749-6632.1988.tb31836.x","volume":"539","author":"W Kristoferitsch","year":"1988","unstructured":"Kristoferitsch W, Sluga E, Graf M, et al. Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features. Ann N Y Acad Sci. 1988;539:35\u201345.","journal-title":"Ann N Y Acad Sci"},{"key":"1530_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1034\/j.1600-0404.2002.01336.x","volume":"106","author":"E Kindstrand","year":"2002","unstructured":"Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E. Peripheral neuropathy in acrodermatitis chronica atrophicans - effect of treatment. Acta Neurol Scand. 2002;106:253\u20137.","journal-title":"Acta Neurol Scand"},{"key":"1530_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/joim.13266","volume":"290","author":"K Ogrinc","year":"2021","unstructured":"Ogrinc K, Maraspin V, Lusa L, Cerar Kisek T, Ruzic-Sabljic E, Strle F. Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients. J Intern Med. 2021;290:335\u201348.","journal-title":"J Intern Med"},{"key":"1530_CR40","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00415-015-8007-x","volume":"263","author":"S Ramgopal","year":"2016","unstructured":"Ramgopal S, Obeid R, Zuccoli G, Cleves-Bayon C, Nowalk A. Lyme disease-related intracranial hypertension in children: clinical and imaging findings. J Neurol. 2016;263:500\u20137.","journal-title":"J Neurol"},{"key":"1530_CR41","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.lanepe.2021.100142","volume":"6","author":"J Ursinus","year":"2021","unstructured":"Ursinus J, Vrijmoeth HD, Harms MG, et al. Prevalence of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study. Lancet Reg Health Eur. 2021;6:100142.","journal-title":"Lancet Reg Health Eur"},{"key":"1530_CR42","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12887-025-05782-7","volume":"25","author":"RA Bruinsma","year":"2025","unstructured":"Bruinsma RA, Skogman BH, van Hensbroek MB, Vermeeren YM, Hovius JW, Zomer TP. Long-term clinical outcomes after Lyme neuroborreliosis in children. BMC Pediatr. 2025;25:511.","journal-title":"BMC Pediatr"},{"key":"1530_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1079\/9781800626225.0000","volume-title":"Lyme disease - an evidence based approach","author":"JJ Halperin","year":"2025","unstructured":"Halperin JJ, Love AC, Wormser GP. Lyme disease - the great controversy. In: Halperin JJ, editor. Lyme disease - an evidence based approach. CABI; 2025. p. 313\u201328."},{"key":"1530_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00234-024-03482-0","volume":"67","author":"ES Lindland","year":"2025","unstructured":"Lindland ES, Rovang MS, Solheim AM, et al. Are white matter hyperintensities associated with neuroborreliosis? The answer is twofold. Neuroradiology. 2025;67:37\u201348.","journal-title":"Neuroradiology"},{"key":"1530_CR45","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3201\/eid2111.150778","volume":"21","author":"JD Forrester","year":"2015","unstructured":"Forrester JD, Kugeler KJ, Perea AE, Pastula DM, Mead PS. No geographic correlation between Lyme disease and death due to 4 neurodegenerative disorders, United States, 2001\u20132010. Emerg Infect Dis. 2015;21:2036\u20139.","journal-title":"Emerg Infect Dis"},{"key":"1530_CR46","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/cid\/ciz997","volume":"71","author":"R Haahr","year":"2020","unstructured":"Haahr R, Tetens MM, Dessau RB, et al. Risk of neurological disorders in patients with European Lyme neuroborreliosis: a nationwide, population-based cohort study. Clin Infect Dis. 2020;71:1511\u20136.","journal-title":"Clin Infect Dis"},{"key":"1530_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jamapsychiatry.2020.2915","volume":"78","author":"MM Tetens","year":"2021","unstructured":"Tetens MM, Haahr R, Dessau RB, et al. Assessment of the risk of psychiatric disorders, use of psychiatric hospitals, and receipt of psychiatric medication among patients with Lyme neuroborreliosis in Denmark. JAMA Psychiat. 2021;78:177\u201386.","journal-title":"JAMA Psychiat"},{"key":"1530_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.14079","author":"MM Tetens","year":"2024","unstructured":"Tetens MM, Graham EE, Andersen NS, et al. No associations between neuroborreliosis in children and psychiatric neurodevelopmental disorders: a nationwide, population-based, matched cohort study. J Child Psychol Psychiatry. 2024. https:\/\/doi.org\/10.1111\/jcpp.14079.","journal-title":"J Child Psychol Psychiatry"},{"key":"1530_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7326\/M15-0333","volume":"163","author":"PJ Molloy","year":"2015","unstructured":"Molloy PJ, Telford SR 3rd, Chowdri HR, et al. Borrelia miyamotoi disease in the Northeastern United States: a case series. Ann Intern Med. 2015;163:91\u20138.","journal-title":"Ann Intern Med"},{"key":"1530_CR50","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/cid\/cix1023","volume":"66","author":"PJ Molloy","year":"2018","unstructured":"Molloy PJ, Weeks KE, Todd B, Wormser GP. Seroreactivity to the C6 peptide in Borrelia miyamotoi infections occurring in the Northeastern United States. Clin Infect Dis. 2018;66:1407\u201310.","journal-title":"Clin Infect Dis"},{"key":"1530_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac107","author":"D Johnston","year":"2022","unstructured":"Johnston D, Kelly JR, Ledizet M, et al. Frequency and geographic distribution of Borrelia miyamotoi, Borrelia burgdorferi, and Babesia microti infections in New England residents. Clin Infect Dis. 2022. https:\/\/doi.org\/10.1093\/cid\/ciac107.","journal-title":"Clin Infect Dis"},{"key":"1530_CR52","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.amjmed.2018.08.012","volume":"132","author":"GP Wormser","year":"2019","unstructured":"Wormser GP, Shapiro ED, Fish D. Borrelia miyamotoi: an emerging tick-borne pathogen. Am J Med. 2019;132:136\u20137.","journal-title":"Am J Med"},{"key":"1530_CR53","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa1209039","volume":"368","author":"JL Gugliotta","year":"2013","unstructured":"Gugliotta JL, Goethert HK, Berardi VP, Telford SR 3rd. Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient. N Engl J Med. 2013;368:240\u20135.","journal-title":"N Engl J Med"},{"key":"1530_CR54","doi-asserted-by":"publisher","first-page":"ofac295","DOI":"10.1093\/ofid\/ofac295","volume":"9","author":"S Gandhi","year":"2022","unstructured":"Gandhi S, Narasimhan S, Workineh A, et al. Borrelia miyamotoi meningoencephalitis in an immunocompetent patient. Open Forum Infect Dis. 2022;9:ofac295.","journal-title":"Open Forum Infect Dis"},{"key":"1530_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1216","author":"PJ Krause","year":"2020","unstructured":"Krause PJ, Auwaerter PG, Bannuru RR, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA): 2020 guideline on diagnosis and management of babesiosis. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1216.","journal-title":"Clin Infect Dis"},{"key":"1530_CR56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/B978-0-444-53490-3.00014-5","volume":"114","author":"S Usmani-Brown","year":"2013","unstructured":"Usmani-Brown S, Halperin JJ, Krause PJ. Neurological manifestations of human babesiosis. Handb Clin Neurol. 2013;114:199\u2013203.","journal-title":"Handb Clin Neurol"},{"key":"1530_CR57","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/319742","volume":"32","author":"JC Hatcher","year":"2001","unstructured":"Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis. 2001;32:1117\u201325.","journal-title":"Clin Infect Dis"},{"key":"1530_CR58","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3201\/eid2906.221890","volume":"29","author":"S Locke","year":"2023","unstructured":"Locke S, O\u2019Bryan J, Zubair AS, et al. Neurologic complications of babesiosis, United States, 2011\u20132021. Emerg Infect Dis. 2023;29:1127\u201335.","journal-title":"Emerg Infect Dis"},{"key":"1530_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071433","author":"I Dumic","year":"2022","unstructured":"Dumic I, Jevtic D, Veselinovic M, et al. Human granulocytic anaplasmosis-a systematic review of published cases. Microorganisms. 2022. https:\/\/doi.org\/10.3390\/microorganisms10071433.","journal-title":"Microorganisms"},{"key":"1530_CR60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.idc.2015.02.007","volume":"29","author":"JS Bakken","year":"2015","unstructured":"Bakken JS, Dumler JS. Human granulocytic anaplasmosis. Infect Dis Clin North Am. 2015;29:341\u201355.","journal-title":"Infect Dis Clin North Am"},{"key":"1530_CR61","doi-asserted-by":"publisher","first-page":"101763","DOI":"10.1016\/j.ttbdis.2021.101763","volume":"12","author":"A Moniuszko-Malinowska","year":"2021","unstructured":"Moniuszko-Malinowska A, Dunaj J, Andersson MO, et al. Anaplasmosis in Poland - analysis of 120 patients. Ticks Tick Borne Dis. 2021;12:101763.","journal-title":"Ticks Tick Borne Dis"},{"key":"1530_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243665","author":"JB Mullholand","year":"2021","unstructured":"Mullholand JB, Tolman N, De Obaldia A, Hennrikus E. Central nervous system involvement of anaplasmosis. BMJ Case Rep. 2021. https:\/\/doi.org\/10.1136\/bcr-2021-243665.","journal-title":"BMJ Case Rep"},{"key":"1530_CR63","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/idr15040035","volume":"15","author":"RJS Cosiquien","year":"2023","unstructured":"Cosiquien RJS, Stojiljkovic N, Nordstrom CW, Amadi E, Lutwick L, Dumic I. Anaplasma phagocytophilum encephalitis: a case report and literature review of neurologic manifestations of anaplasmosis. Infect Dis Rep. 2023;15:354\u20139.","journal-title":"Infect Dis Rep"},{"key":"1530_CR64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12879-018-3321-4","volume":"18","author":"SW Kim","year":"2018","unstructured":"Kim SW, Kim CM, Kim DM, Yun NR. Manifestation of anaplasmosis as cerebral infarction: a case report. BMC Infect Dis. 2018;18:409.","journal-title":"BMC Infect Dis"},{"key":"1530_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","volume":"65","author":"HM Biggs","year":"2016","unstructured":"Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep. 2016;65:1\u201344.","journal-title":"MMWR Recomm Rep"},{"key":"1530_CR66","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00083-18","author":"S Madison-Antenucci","year":"2020","unstructured":"Madison-Antenucci S, Kramer LD, Gebhardt LL, Kauffman E. Emerging tick-borne diseases. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/CMR.00083-18.","journal-title":"Clin Microbiol Rev"},{"key":"1530_CR67","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.1990.03450170099030","volume":"264","author":"TR Eng","year":"1990","unstructured":"Eng TR, Harkess JR, Fishbein DB, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA. 1990;264:2251\u20138.","journal-title":"JAMA"},{"key":"1530_CR68","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00415-025-13347-y","volume":"272","author":"JC Garcia-Monco","year":"2025","unstructured":"Garcia-Monco JC, Benach JL. Tick-induced neurological disorders. J Neurol. 2025;272:599.","journal-title":"J Neurol"},{"key":"1530_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071420","author":"B Kohlmaier","year":"2010","unstructured":"Kohlmaier B, Schweintzger NA, Sagmeister MG, et al. Clinical characteristics of patients with tick-borne encephalitis (TBE): a European multicentre study from 2010 to 2017. Microorganisms. 2010. https:\/\/doi.org\/10.3390\/microorganisms9071420.","journal-title":"Microorganisms"},{"key":"1530_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens15050535","author":"G Trozzi","year":"2026","unstructured":"Trozzi G, Sohier C, De Regge N. Current knowledge on tick-borne encephalitis virus interaction with ticks: acquisition, dissemination, and persistence. Pathogens. 2026. https:\/\/doi.org\/10.3390\/pathogens15050535.","journal-title":"Pathogens"},{"key":"1530_CR71","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ttbdis.2019.02.014","volume":"10","author":"S Han","year":"2019","unstructured":"Han S, Lubelczyk C, Hickling GJ, Belperron AA, Bockenstedt LK, Tsao JI. Vertical transmission rates of Borrelia miyamotoi in Ixodes scapularis collected from white-tailed deer. Ticks Tick Borne Dis. 2019;10:682\u20139.","journal-title":"Ticks Tick Borne Dis"},{"key":"1530_CR72","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ttbdis.2018.07.006","volume":"9","author":"NE Breuner","year":"2018","unstructured":"Breuner NE, Hojgaard A, Replogle AJ, Boegler KA, Eisen L. Transmission of the relapsing fever spirochete, Borrelia miyamotoi, by single transovarially-infected larval Ixodes scapularis ticks. Ticks Tick Borne Dis. 2018;9:1464\u20137.","journal-title":"Ticks Tick Borne Dis"},{"key":"1530_CR73","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/vbz.2017.2239","volume":"18","author":"ER Krow-Lucal","year":"2018","unstructured":"Krow-Lucal ER, Lindsey NP, Fischer M, Hills SL. Powassan virus disease in the United States, 2006\u20132016. Vector Borne Zoonotic Dis. 2018;18:286\u201390.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"1530_CR74","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1183","author":"HM Feder","year":"2020","unstructured":"Feder HM, Telford S, Goethert HK, Wormser GP. Powassan virus encephalitis following brief attachment of Connecticut deer ticks. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1183.","journal-title":"Clin Infect Dis"},{"key":"1530_CR75","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3201\/eid2308.161971","volume":"23","author":"HM Frost","year":"2017","unstructured":"Frost HM, Schotthoefer AM, Thomm AM, et al. Serologic evidence of Powassan virus infection in patients with suspected Lyme disease(1). Emerg Infect Dis. 2017;23:1384\u20138.","journal-title":"Emerg Infect Dis"},{"key":"1530_CR76","unstructured":"CDC. Powassan virus [online]. Available at: https:\/\/www.cdc.gov\/powassan\/hcp\/diagnosis-testing\/index.html#print, https:\/\/www.cdc.gov\/powassan\/hcp\/clinical-signs\/index.html, https:\/\/www.cdc.gov\/powassan\/hcp\/treatment-prevention\/index.html#print. Accessed Aug 10."},{"key":"1530_CR77","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3201\/eid2504.181509","volume":"25","author":"GP Wormser","year":"2019","unstructured":"Wormser GP, McKenna D, Scavarda C, et al. Co-infections in persons with early Lyme disease, New York, USA. Emerg Infect Dis. 2019;25:748\u201352.","journal-title":"Emerg Infect Dis"},{"key":"1530_CR78","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/cid\/ciad454","volume":"78","author":"MA Mendoza","year":"2024","unstructured":"Mendoza MA, Hass RM, Vaillant J, et al. Powassan virus encephalitis: a tertiary center experience. Clin Infect Dis. 2024;78:80\u20139.","journal-title":"Clin Infect Dis"},{"key":"1530_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed8120508","author":"L Kakoullis","year":"2023","unstructured":"Kakoullis L, Vaz VR, Kaur D, et al. Powassan virus infections: a systematic review of published cases. Trop Med Infect Dis. 2023. https:\/\/doi.org\/10.3390\/tropicalmed8120508.","journal-title":"Trop Med Infect Dis"},{"key":"1530_CR80","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1056\/NEJMoa0806326","volume":"360","author":"NP Tavakoli","year":"2009","unstructured":"Tavakoli NP, Wang H, Dupuis M, et al. Fatal case of deer tick virus encephalitis. N Engl J Med. 2009;360:2099\u2013107.","journal-title":"N Engl J Med"},{"key":"1530_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/NRL.0000000000000533","volume":"29","author":"PF Finelli","year":"2024","unstructured":"Finelli PF. MR imaging patterns and prognosis in Powassan virus encephalitis. Neurologist. 2024;29:103\u20135.","journal-title":"Neurologist"},{"key":"1530_CR82","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3201\/eid2209.152034","volume":"22","author":"K Boden","year":"2016","unstructured":"Boden K, Lobenstein S, Hermann B, Margos G, Fingerle V. Borrelia miyamotoi-associated neuroborreliosis in immunocompromised person. Emerg Infect Dis. 2016;22:1617\u201320.","journal-title":"Emerg Infect Dis"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01530-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01530-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01530-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:02:46Z","timestamp":1792530166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01530-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1530"],"URL":"https:\/\/doi.org\/10.1007\/s11910-026-01530-1","relation":{},"ISSN":["1534-6293"],"issn-type":[{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"24 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JH has served as a consultant for Pfizer, No other competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies with human or animal subjects are published and followed ethical standards.","order":2,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}